Leap Investments’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Leap Investments’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$73K	Buy	+1,210	New	+$111K	0.05%	367
2019 Q3	–	Sell	-1,220	Closed	-$171K	–	521
2019 Q2	$171K	Buy	+1,220	New	+$214K	0.23%	174

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Leap Investments's ORTX Position: Q2 2020 in Review

Leap Investments opened a new position in Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2020: 1,210 shares worth $73K. The stake represents 0.05% of the portfolio and ranks #367 among its holdings. This is a return to the name: Leap Investments previously reported a position in ORTX as recently as Q2 2019.

Leap Investments first reported a position in ORTX in Q2 2019 and has held it in 2 quarters since. The position peaked at $171K in Q2 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q2 2020.

Leap Investments held 1,210 shares of Orchard Therapeutics plc American Depositary Shares worth $73K as of Q2 2020.
Orchard Therapeutics plc American Depositary Shares was a new Leap Investments position in Q2 2020.
Orchard Therapeutics plc American Depositary Shares made up 0.05% of Leap Investments's portfolio in Q2 2020, its #367 holding.
Leap Investments first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and has held it in 2 quarters since.
Leap Investments's Orchard Therapeutics plc American Depositary Shares position peaked at $171K in Q2 2019.
81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.